Neogen Corporation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
Neogen Corporation (NEOG) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $7.19 million for the 12-month period ending 2023-05-31, per its 10-K filed 2025-07-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2025-07-30
- Neogen Corporation effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2023-02-28 was $1.10M.
- Neogen Corporation effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2022-11-30 was $6.70M.
- Neogen Corporation effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was $7.19M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 6 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month |
|---|---|---|---|
| 2023-05-31 | $7.19M 10-K · filed 2025-07-30 | ||
| 2023-02-28 | $1.10M 10-Q · filed 2023-04-04 | $7.80M derived: sum of 2 quarters · filed 2023-04-04 | |
| 2022-11-30 | $6.70M 10-Q · filed 2023-01-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |